Format

Send to

Choose Destination
Andrologia. 2016 Feb;48(1):69-73. doi: 10.1111/and.12420. Epub 2015 May 8.

Oxidative stress in benign prostate hyperplasia.

Author information

1
Laboratory of Molecular Toxicology, Department of Molecular and Cellular Biology, Faculty of Science, University of Jijel, Jijel, Algeria.
2
Urology Service, Mohammed Essedik Benyahiya Jijel Hospital, Jijel, Algeria.
3
UMR CNRS6293-Clermont University-INSERM U1103 Campus Universitaire des CĂ©zeaux, Cmlermont Ferand, France.

Abstract

To assess the status of oxidative stress in benign prostate hyperplasia, a very common disease in older men which constitutes a public health problem in Jijel, prostate tissues were obtained by transvesical adenomectomy from 10 men with benign prostate hyperplasia. We measured the cytosolic levels of malondialdehyde (MDA) and glutathione (GSH) and cytosolic enzyme activities of superoxide dismutase, catalase, glutathione peroxidase and glutathione S-transferase. The development of benign prostate hyperplasia is accompanied by impaired oxidative status by increasing levels of MDA, depletion of GSH concentrations and a decrease in the activity of all the antioxidant enzymes studied. These results have allowed us to understand a part of the aetiology of benign prostate hyperplasia related to oxidative stress.

KEYWORDS:

Antioxidant enzymes; MDA; benign prostate hyperplasia; glutathione; oxidative stress

PMID:
25959539
DOI:
10.1111/and.12420
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center